Bristol-Myers Squibb buy BiotechBee
Start price
07.09.22
/
70%
€69.37
Target price
31.12.25
€100.00
Performance (%)
-12.07%
End price
05.05.23
€61.00
Summary
This prediction ended on 05.05.23 with a price of €61.00. The prediction for Bristol-Myers Squibb disappointed with a performance of -12.07%. A total of €1.61 was paid as dividends for this prediction. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | 4.023% | 4.023% | 37.600% | 1.056% |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % | 64,25 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % | 84,97 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % | 79,25 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % | 68,08 % |
According to BiotechBee what are the pros and cons of Bristol-Myers Squibb for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Bristol-Myers Squibb diskutieren
Buy mit Kursziel 100,0